|1.||Duggan, Christopher: 2 articles (11/2012 - 10/2005)|
|2.||Puder, Mark: 2 articles (04/2011 - 10/2005)|
|3.||Gura, Kathleen M: 2 articles (04/2011 - 10/2005)|
|4.||Goulet, Olivier: 2 articles (05/2010 - 06/2009)|
|5.||Williamson, Eric E: 1 article (11/2015)|
|6.||McMahon, M Molly: 1 article (11/2015)|
|7.||Frazee, Erin N: 1 article (11/2015)|
|8.||Nystrom, Erin M: 1 article (11/2015)|
|9.||Miles, John M: 1 article (11/2015)|
|10.||Chauhan, Anuj: 1 article (08/2015)|
08/01/1982 - "This study suggests that intravenous fat emulsions are utilized as an energy substrate in patients with major injury, infection or nutritional depletion. "
09/01/1993 - "Malassezia furfur infection has been associated with intravenous fat emulsions infused through central venous lines. "
07/01/1987 - "The role of the lipophilic nature of Malassezia in the pathogenesis of infection is apparent from the ability of intravenous fat emulsions to support the growth of the fungus in vitro. "
07/01/1987 - "The use of intravenous fat emulsions appears to have altered the microenvironment of the catheter and allowed colonization and subsequent infection. "
01/01/1992 - "Intravenous fat emulsions appear to be a safe component of intravenous nutritional support for the patient with pancreatitis, based on multiple studies proving their safety in a total of nearly 100 patients. "
01/01/1992 - "It seems prudent to avoid hypertriglyceridemia secondary to intravenous fat emulsions, as this alone is a cause of pancreatitis, albeit uncommon, in patients with abnormalities of triglyceride metabolism. "
01/01/1992 - "Intravenous fat emulsions may rarely cause pancreatitis; this may be more likely in patients with Crohn's disease, given that three of the four reported cases occurred in patients with Crohn's disease. "
02/01/1984 - "The various relationships between pancreatitis, alcoholism, and hyperlipemia are not clear, and guidelines for the use of intravenous fat emulsions in patients with pancreatitis should take into account their complex interrelationship."
|3.||Liver Diseases (Liver Disease)
10/01/2014 - "The high incidence of liver disease associated with intravenous soybean lipid has led to development and use of alternative intravenous lipid emulsions (ILEs). "
06/01/2009 - "View on liver disease has recently evolved with the onset of fish oil-based intravenous lipid emulsions (ILE). "
03/01/2012 - "Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease."
04/01/2011 - "Plant-based intravenous lipid emulsions have been shown to contribute to parenteral nutrition-associated liver disease (PNALD). "
05/01/2010 - "Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease."
12/01/1984 - "Broviac catheter-related Malassezia furfur sepsis in five infants receiving intravenous fat emulsions."
12/01/2011 - "Comparison of the effects of different intravenous fat emulsions in patients with systemic inflammatory response syndrome and sepsis."
08/01/2001 - "Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis."
09/01/1985 - "Use of intravenous lipid emulsions in trauma and sepsis still remains controversial. "
|5.||Critical Illness (Critically Ill)
12/01/2013 - "Infectious complications with nondaily versus daily infusion of intravenous fat emulsions in non-critically ill adults."
07/01/2013 - "Steps forward, backward, and sideways: intravenous lipid emulsions for critically ill neonates."
02/01/1998 - "Twenty critically-ill surgical patients who needed total parenteral nutrition were randomly enrolled in a double-blind study comparing two intravenous fat emulsions: one containing a mixture of 50% medium-chain triglycerides and 50% long-chain triglycerides and another containing 100% longchain triglycerides. "
|3.||Essential Fatty Acids
|4.||Omega-6 Fatty Acids (Omega 6 Fatty Acids)
|6.||Omega-3 Fatty Acids (Omega 3 Fatty Acids)
|8.||Prostaglandins E (PGE)
|9.||Corn Oil (Oil, Corn)
|1.||Nutritional Support (Artificial Feeding)
|4.||Intensive Care (Surgical Intensive Care)
|5.||Total Parenteral Nutrition